{"id":"https://openalex.org/W7225630837","doi":"https://doi.org/10.6084/m9.figshare.34956381","title":"Bioanalysis of antibody\u2013drug conjugates: current practices and future directions\u2014a workshop report","display_name":"Bioanalysis of antibody\u2013drug conjugates: current practices and future directions\u2014a workshop report","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225630837","doi":"https://doi.org/10.6084/m9.figshare.34956381"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.34956381","doi":"https://doi.org/10.6084/m9.figshare.34956381","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34956381","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.34956381","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161304405","display_name":"Weifeng Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Weifeng Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007169910","display_name":"Tushar S. Garimella","orcid":"https://orcid.org/0000-0001-8792-5513","observed_orcids":["https://orcid.org/0000-0001-8792-5513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tushar Garimella","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161315103","display_name":"Brian Booth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Booth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050449302","display_name":"N. Ezgi Wood","orcid":"https://orcid.org/0000-0002-1874-9226","observed_orcids":["https://orcid.org/0000-0002-1874-9226"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Ezgi Wood","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005988952","display_name":"Ola M. Saad","orcid":"https://orcid.org/0000-0002-2607-8901","observed_orcids":["https://orcid.org/0000-0002-2607-8901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ola M. Saad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100690922","display_name":"Ang Liu","orcid":"https://orcid.org/0000-0001-9353-0948","observed_orcids":["https://orcid.org/0000-0001-9353-0948","https://orcid.org/0009-0003-3518-9050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ang Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112699601","display_name":"Li Wenkui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenkui Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005799156","display_name":"Faye Vazvaei-Smith","orcid":"https://orcid.org/0000-0002-8181-8335","observed_orcids":["https://orcid.org/0000-0002-8181-8335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Faye Vazvaei-Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9629999995231628},{"id":"https://openalex.org/keywords/bioanalysis","display_name":"bioanalysis","score":0.8410000205039978},{"id":"https://openalex.org/keywords/risk-based-approach","display_name":"risk-based approach","score":0.6740000247955322},{"id":"https://openalex.org/keywords/clinical-pharmacology","display_name":"clinical pharmacology","score":0.7670000195503235},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.9359999895095825},{"id":"https://openalex.org/keywords/exposure-response-model","display_name":"exposure-response modeling","score":0.921999990940094},{"id":"https://openalex.org/keywords/immunogenicity-assessment","display_name":"immunogenicity assessment","score":0.925000011920929},{"id":"https://openalex.org/keywords/lc-ms-ms","display_name":"LC-MS/MS","score":0.859000027179718},{"id":"https://openalex.org/keywords/regulatory-aspects","display_name":"regulatory considerations","score":0.7950000166893005},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.6589999794960022},{"id":"https://openalex.org/keywords/regulatory-alignment","display_name":"regulatory alignment","score":0.47999998927116394}],"concepts":[{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.7142000198364258},{"id":"https://openalex.org/C137535248","wikidata":"https://www.wikidata.org/wiki/Q4914691","display_name":"Bioanalysis","level":2,"score":0.5347999930381775},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.5163999795913696},{"id":"https://openalex.org/C108170787","wikidata":"https://www.wikidata.org/wiki/Q3951828","display_name":"Agency (philosophy)","level":2,"score":0.474700003862381},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.4334000051021576},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.4242999851703644},{"id":"https://openalex.org/C3019398576","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory agency","level":2,"score":0.41929998993873596},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.3659000098705292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35510000586509705},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.34630000591278076},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3424000144004822},{"id":"https://openalex.org/C184356942","wikidata":"https://www.wikidata.org/wiki/Q830382","display_name":"Best practice","level":2,"score":0.33410000801086426},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.3262999951839447},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.3197999894618988},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.3197999894618988},{"id":"https://openalex.org/C2522767166","wikidata":"https://www.wikidata.org/wiki/Q2374463","display_name":"Data science","level":1,"score":0.3133000135421753},{"id":"https://openalex.org/C110354214","wikidata":"https://www.wikidata.org/wiki/Q6314146","display_name":"Engineering management","level":1,"score":0.3127000033855438},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.3073999881744385},{"id":"https://openalex.org/C2909155969","wikidata":"https://www.wikidata.org/wiki/Q6055890","display_name":"Funding Agency","level":2,"score":0.29980000853538513},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.2957000136375427},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.29269999265670776},{"id":"https://openalex.org/C3020792226","wikidata":"https://www.wikidata.org/wiki/Q1331083","display_name":"Human use","level":2,"score":0.29179999232292175},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2897000014781952},{"id":"https://openalex.org/C195094911","wikidata":"https://www.wikidata.org/wiki/Q14167904","display_name":"Process management","level":1,"score":0.2766999900341034},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2734000086784363},{"id":"https://openalex.org/C2779965156","wikidata":"https://www.wikidata.org/wiki/Q5227350","display_name":"Data sharing","level":3,"score":0.2728999853134155},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.26660001277923584},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.26330000162124634},{"id":"https://openalex.org/C106436119","wikidata":"https://www.wikidata.org/wiki/Q836575","display_name":"Quality assurance","level":3,"score":0.2526000142097473},{"id":"https://openalex.org/C2778091849","wikidata":"https://www.wikidata.org/wiki/Q4959649","display_name":"Breakout","level":2,"score":0.2515000104904175},{"id":"https://openalex.org/C2777720028","wikidata":"https://www.wikidata.org/wiki/Q18394118","display_name":"Responsible Research and Innovation","level":2,"score":0.250900000333786}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.34956381","doi":"https://doi.org/10.6084/m9.figshare.34956381","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34956381","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.34956381.v1","doi":"https://doi.org/10.6084/m9.figshare.34956381.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34956381.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.34956381","doi":"https://doi.org/10.6084/m9.figshare.34956381","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34956381","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1981480968","https://openalex.org/W7166837932","https://openalex.org/W4297236733","https://openalex.org/W1998924448","https://openalex.org/W2604840086","https://openalex.org/W2417088662","https://openalex.org/W7117977938","https://openalex.org/W4292736875","https://openalex.org/W2989087245","https://openalex.org/W4409314540"],"abstract_inverted_index":{"The":[0,27],"International":[1],"Consortium":[2],"for":[3,43,154],"Innovation":[4],"and":[5,35,63,77,79,99,101,140,143,160],"Quality":[6],"in":[7,20,23,137,163],"Pharmaceutical":[8],"Development":[9],"(IQ)":[10],"convened":[11],"a":[12,152],"workshop":[13],"on":[14,54,59,72],"bioanalysis":[15],"of":[16,88,123,134],"antibody\u2013drug":[17],"conjugates":[18],"(ADCs)":[19],"March":[21],"2026,":[22],"Spring":[24],"House,":[25],"Pennsylvania.":[26],"one-day":[28],"event":[29],"brought":[30],"together":[31],"pharmaceutical":[32],"industry":[33,52],"scientists":[34],"regulatory":[36,64,115,161],"agency":[37],"representatives":[38],"to":[39,146],"discuss":[40],"bioanalytical":[41,157],"strategies":[42,104],"ADC":[44,60,156],"development.":[45],"This":[46],"report":[47],"summarizes":[48],"key":[49],"presentations\u2014including":[50],"an":[51],"survey":[53],"the":[55,120,131],"current":[56],"practices,":[57],"perspectives":[58],"clinical":[61],"pharmacology,":[62],"considerations\u2014along":[65],"with":[66],"findings":[67],"from":[68],"breakout":[69],"sessions":[70],"focused":[71],"preclinical":[73],"bioanalysis,":[74],"pharmacokinetic":[75],"assays":[76],"modeling,":[78],"immunogenicity":[80,147],"assessments.":[81],"Workshop":[82],"participants":[83],"generally":[84],"supported":[85,109],"early":[86],"characterization":[87],"relevant":[89],"ADC-related":[90],"analytes,":[91],"emphasizing":[92],"that":[93,102],"analyte":[94],"selection":[95],"should":[96],"remain":[97],"risk-based":[98,144],"molecule-specific":[100],"measurement":[103],"may":[105],"be":[106],"streamlined":[107],"when":[108,113],"by":[110],"data":[111],"and,":[112],"appropriate,":[114],"consultation.":[116],"Emerging":[117],"themes":[118],"included":[119],"growing":[121],"use":[122],"hybrid":[124],"liquid":[125],"chromatography\u2013tandem":[126],"mass":[127],"spectrometry":[128],"(LC\u2013MS/MS)":[129],"platforms,":[130],"central":[132],"role":[133],"exposure-response":[135],"modeling":[136],"dose":[138],"optimization":[139],"assay":[141],"strategy,":[142],"approaches":[145],"assessment.":[148],"These":[149],"discussions":[150],"provide":[151],"foundation":[153],"advancing":[155],"best":[158],"practices":[159],"alignment":[162],"this":[164],"rapidly":[165],"evolving":[166],"therapeutic":[167],"area.":[168]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}